September 24, 2012

Prestige Brands on Monday announced the launch of Goody's in a caplet format.

September 20, 2012

Drug maker Dr. Reddy's Labs has launched a generic antibiotic drug, the company said Thursday.

September 20, 2012

Procter & Gamble this week will begin shipping a wildberry-flavored Prilosec OTC.

September 12, 2012

GlaxoSmithKline is offering a recycling program for empty inhalers at retail pharmacies in 31 cities, the drug maker said Wednesday.

September 12, 2012

Most advertisements for over-the-counter versions of drugs did contain significantly less information about the risks of the medication, compared with the ads for the drug prior to its transition to OTC status, according to new research sponsored by CVS Caremark.

September 4, 2012

The Food and Drug Administration has approved a generic antidepressant made by Wockhardt, the Indian drug maker said Tuesday.

August 23, 2012

A division of Johnson & Johnson has started a late-stage clinical trial program for a drug for rheumatoid arthritis under a partnership with British drug maker GlaxoSmithKline.

August 17, 2012

Procter & Gamble’s Prilosec OTC still is the best-selling antacid on the market, with more than $252.7 million in annual sales for the 52 weeks ended July 8 across food, drug and mass (excluding Walmart), followed by fellow proton-pump inhibitor Novartis’ Prevacid 24HR ($104.1 million).


August 14, 2012

The Food and Drug Administration has approved the formulation for the 2012-2013 flu vaccine, the agency said Monday.

August 7, 2012

A new quality improvement initiative that aims to disseminate newly designed patient medication information to patients filling prescriptions at participating pharmacies has been launched.

July 31, 2012

Following regulatory approval by the Food and Drug Administration's Center for Biologics Evaluation and Research, GlaxoSmithKline confirmed it has begun shipping the first lots of its 2012-2013 seasonal influenza vaccines to healthcare providers and Centers for Disease Control and Prevention distribution centers.

July 30, 2012

Stiefel, a GlaxoSmithKline company, announced the availability of Sorilux foam by prescription.

July 30, 2012

As reported by Drug Store News, toothpastes that aim to better deliver such 
value-added benefits as teeth whitening and relieving tooth sensitivity are resonating with consumers, so the lift in sales of such products comes as little surprise.


July 16, 2012

British drug maker GlaxoSmithKline will acquire development partner Human Genome Sciences for $3.6 billion, GSK said Monday.

July 16, 2012

Prestige Brands earlier this year completed its acquisition of 17 GlaxoSmithKline brands. Drug Store News sat with Prestige SVP sales and marketing Tim Connors to discuss what’s next.


July 13, 2012

GlaxoSmithKline and Theravance submitted a regulatory application to the Food and Drug Administration for their chronic obstructive pulmonary disease treatment.

July 9, 2012

GlaxoSmithKline on Monday issued an email blast to registrants of its MyAlli.com site that Alli will be making its way back to store shelves later this month.

June 21, 2012

This may be the year of the legacy brands as two companies that recently acquired separate brand portfolios from GlaxoSmithKline focus on reinvigorating consumer attention to their respective product lines.


June 15, 2012

GlaxoSmithKline has received regulatory approval from the Food and Drug Administration for a vaccine designed to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type B.

June 14, 2012

Stiefel, a GlaxoSmithKline company, on Monday acquired the eczema remedy Toctino (alitretinoin) from Basilea Pharmaceutica.

June 11, 2012

GlaxoSmithKline again has extended an unsolicited tender offer to acquire Human Genome Sciences.

June 7, 2012

Dr. Reddy's Labs has launched a drug for treating Parkinson's disease, the company said Thursday.

June 7, 2012

The Food and Drug Administration has approved a drug made by GlaxoSmithKline and XenoPort for treating pain associated with shingles.

June 4, 2012

One month after GlaxoSmithKline announced its tender offer to acquire Human Genome Sciences, HGS said Friday that its board of directors has rejected the unsolicited bid.